Ted Kellner, as the nominating stockholder and a nominee, together with his other nominees, Todd Deutsch, Robert L. Chioini and Paul W. Sweeney (collectively, the “Kellner Group,” “we” or “us” and, as nominees, the “Kellner Group Nominees”), issues this urgent statement in response to baseless, deceptive rumors and in connection with their efforts to bring accountability to the entrenched, incumbent Board of Directors of AIM Immunotech Inc. (NYSE American: AIM).

Kellner Group has Never Shorted AIM Stock

Equels and Incumbent Board are the Problem. We are the Solution.

Ted Kellner and Todd Deutsch are long-term, significant AIM stockholders. Neither has traded AIM stock at all recently. The Kellner Group is collectively the largest AIM stockholder and our interest is squarely aligned with maximizing value for all stockholders. We are committed to delivering the urgent change that AIM desperately needs. We have no motive other than to salvage AIM and create value for all stockholders

It has come to our attention that lies are being spread that we are involved in short selling AIM stock. These claims are absolutely false.

Nobody in the Kellner Group has ever engaged in shorting AIM stock. If Equels, other AIM representatives and anybody else is claiming otherwise, they are lying. It is absolutely false that there was any shred of evidence to the contrary in past legal proceedings.  

The only truth is that the incumbent Board desperately and unsuccessfully tried to fabricate yet another lie about Ted Kellner in the Delaware court proceedings. Mr. Kellner jotted a note about concerns with potential short selling—concerns that are entirely justified and shared by any legitimate stockholder who cares about AIM’s future! These concerns were not a sign of any involvement in short selling; rather, they were a clear reflection of the risks stockholders face when the Board utterly fails to serve shareholders and prioritizes their own self-interests at the expense of the company’s future.   It is yet another example of the deceitful tactics employed by Equels and the other incumbent AIM directors, whose entire campaign against us has been built on gross deception. They have completely failed stockholders, and this is the only strategy they have left—lying and misdirecting attention from their own incompetence.

The Real Problem Lies with the Incumbent Board.

The incumbent Board, led by Mr. Equels, has failed AIM and its stockholders at every turn. They have allowed AIM’s stock price to fall and failed to attract meaningful interest from institutional investors or the broader market. The short sellers are not afraid of getting squeezed because the incumbent Board has no credibility and regardless of what AIM announces, they know the Board won’t deliver results and are unable to attract investor interest. This is a crisis that will not fix itself, and AIM cannot afford to continue down this destructive path.

The solution is clear: the Kellner Group offers the leadership, experience, and vision necessary to restore AIM to its rightful potential. Electing the Kellner Group will bring the decisive action needed to drive performance and create real value for stockholders that will lead the shorts and manipulators will run for the hills. 

The stock only goes one way with Equels and the other incumbent AIM directors in control – down! 

Vote FOR all four Kellner Group nominees today to change this and AIM’s future! 

We are the solution to AIM’s problems!

We urge all AIM stockholders that care about its future to carefully read our open letter to stockholders issued as a press release yesterday, available at https://okapivote.com/aim.

THE KELLNER GROUP URGES ALL STOCKHOLDERS TO VOTE ON THE GOLD PROXY CARD TODAY TO ELECT TED D. KELLNER, TODD DEUTSCH, ROBERT L. CHIOINI AND PAUL SWEENEY

If you have any questions, require assistance in voting your GOLD proxy card, or need additional copies of the Kellner Group’s proxy materials, please contact Okapi Partners at the phone numbers or email address listed below. Please also visit https://okapivote.com/AIM/ for additional information.

Contact:

Okapi Partners LLC1212 Avenue of the Americas, 17th Floor,New York, New York 10036Stockholders may call toll-free: (844) 343-2621Banks and brokers call: (212) 297-0720Email: info@okapipartners.com 

Important Information and Participants in the Solicitation

The Kellner Group has filed a definitive proxy statement and associated GOLD proxy card with the Securities and Exchange Commission (“SEC”) to be used to solicit votes for the election of its slate of highly-qualified director nominees at the upcoming annual meeting of stockholders of AIM. Details regarding the Kellner Group nominees are included in its proxy statement.

THE KELLNER GROUP STRONGLY ADVISES ALL STOCKHOLDERS OF AIM TO READ THE PROXY STATEMENT AND OTHER PROXY MATERIALS AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION.

Information regarding the identity of participants in the Kellner Group’s solicitation, and their direct or indirect interests, by security holdings or otherwise, is set forth in the Kellner Group’s proxy statement and additional proxy materials filed with the SEC. Stockholders can obtain a copy of the proxy statement, and any amendments or supplements thereto and other documents filed by the Kellner Group with the SEC for no charge at the SEC’s website at www.sec.gov. Copies will also be available at no charge at the following website: https://www.okapivote.com/AIM. Investors can also contact Okapi Partners LLC at the telephone number or email address set for the above.

AIM ImmunoTech (AMEX:AIM)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more AIM ImmunoTech Charts.
AIM ImmunoTech (AMEX:AIM)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more AIM ImmunoTech Charts.